Cognum

As part of complex therapy:

• cognitive impairment in organic brain lesions (including the effects of neuroinfection and traumatic brain injury);
• cerebrovascular insufficiency caused by atherosclerotic changes in cerebral vessels;
• extrapyramidal disorders (myoclonus epilepsy, Huntington’s chorea, hepatolenticular degeneration, Parkinson’s disease);
• epilepsy with slowing down of mental processes (in combination with anticonvulsants);
• psycho-emotional overload, decreased mental and physical performance (to improve concentration and memorization);
• neurogenic urinary disorders: enuresis, pollakiuria, urgency, urge incontinence;
• the medicine is indicated in children over 3 years of age with perinatal encephalopathy, mental retardation of varying severity, developmental delay (mental, speech, motor), various forms of cerebral palsy, hyperkinetic disorders (attention deficit hyperactivity disorder, tics), stuttering (mainly clonic form), neurosis-like conditions.